author-photo

Sai Li

Hoffmann-La Roche

2

Papers

26

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial

2016 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (26)
Non-Inferior Pharmacokinetics with Comparable Safety and Response Rates for Subcutaneous (SC), Compared with Intravenous (IV), Rituximab in Combination with Fludarabine and Cyclophosphamide (FC) in Patients (Pts) with Untreated Chronic Lymphocytic Leukemia (CLL): Part 2 of the Phase Ib SAWYER Study (BO25341)

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)